Assessment of second-line antiretroviral regimens for HIV therapy in Africa by Paton, N, Kityo, C, Walker, A, al., E

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study by Inzaule, S, Hamers, R, Kityo, C, Rinke de Wit, T, Roura, M

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans by Nanzigu S, Kiguba R, Kabanda J, Mukonzo JK, Waako P, Kityo C, Makumbi F

Get full text

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe. by Jaganath, D, Walker, A, Ssali, F, Musiime, V, Kiweewa, F, Kityo, C, Salata, R, Mugyenyi, P

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. by Kiwuwa-Muyingo, S, Walker, A, Oja, H, Levin, J, Miiro, G, Katabira, E, Kityo, C, Hakim, J, Todd, J

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART. by Munderi, P, Snowden, W, Walker, A, Kityo, C, Mosteller, M, Kabuye, G, Thoofer, N, Ssali, F, Gilks, C, Hughes, A

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial by Parikh, S, Obuku, E, Walker, SA, Semeere, A, Auerbach, B, Hakim, J, Mayanja-Kizza, H, Mugyenyi, P, Salata, R, Kityo, C

Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study by Arrigoni, FIF, Spyer, M, Hunter, P, Alber, D, Kityo, C, Hakim, J, Matubu, A, Olal, P, Paton, NI, Walker, AS, Klein, N

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. by Stöhr, W, Reid, A, Walker, A, Ssali, F, Munderi, P, Mambule, I, Kityo, C, Grosskurth, H, Gilks, C, Gibb, D, Hakim, J

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine... by Munderi, P, Walker, A, Kityo, C, Babiker, A, Ssali, F, Reid, A, Darbyshire, J, Grosskurth, H, Mugyenyi, P, Gibb, D, Gilks, C

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study. by Gomo, Z, Hakim, J, Walker, SA, Tinago, W, Mandozana, G, Kityo, C, Munderi, P, Katabira, E, Reid, A, Gibb, D, Gilks, C

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria by Gilks, C, Walker, A, Munderi, P, Kityo, C, Reid, A, Katabira, E, Goodall, R, Grosskurth, H, Mugyenyi, P, Hakim, J, Gibb, D

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Kityo, C, Gibb, D, Gilks, C, Goodall, R, Mambule, I, Kaleebu, P, Pillay, D, Kasirye, R, Mugyenyi, P, Walker, A, Dunn, D

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets by Bienczak, A, Denti, P, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Keketiinwa, A, Gibb, D, Burger, D, Walker, A, McIlleron, H

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. by Reid, A, Stöhr, W, Walker, A, Williams, I, Kityo, C, Hughes, P, Kambugu, A, Gilks, C, Mugyenyi, P, Munderi, P, Hakim, J, Gibb, D

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects by Haberer, J, Cook, A, Walker, A, Ngambi, M, Ferrier, A, Mulenga, V, Kityo, C, Thomason, M, Kabamba, D, Chintu, C, Gibb, D, Bangsberg, DR

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study by Inzaule, S, Hamers, R, Noguera-Julian, M, Casadellà, M, Parera, M, Kityo, C, Steegen, K, Naniche, D, Clotet, B, Rinke De Wit, T, Paredes, R, Resistance, P

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. by Walker, A, Prendergast, A, Mugyenyi, P, Munderi, P, Hakim, J, Kekitiinwa, A, Katabira, E, Gilks, C, Kityo, C, Nahirya-Ntege, P, Nathoo, K, Gibb, D

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults. by Kityo, C, Walker, A, Dickinson, L, Lutwama, F, Kayiwa, J, Ssali, F, Nalumenya, R, Tumukunde, D, Munderi, P, Reid, A, Gilks, C, Gibb, D, Khoo, S

Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analys... by Thompson, J, Kityo, C, Dunn, D, Hoppe, A, Ndashimye, E, Hakim, J, Kambugu, A, van Oosterhout, J, Arribas, J, Mugyenyi, P, Walker, A, Paton, N